IL10 and inflammatory bowel disease: Furthermore, the presence of Escherichia-Shigella, a virulent pathogen known to promote IBD (Feng et al. 2020), decreased after administration of EcN-TNFαNb and EcN-IL10 in DSS-treated mice at the genus level (Fig. 4C).